Zura Bio Limited (ZURA)
(Delayed Data from NSDQ)
$4.47 USD
+0.17 (3.95%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $4.49 +0.02 (0.45%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ZURA 4.47 +0.17(3.95%)
Will ZURA be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for ZURA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZURA
Wall Street Analysts Predict a 235.2% Upside in Zura Bio Limited (ZURA): Here's What You Should Know
How Much Upside is Left in Zura Bio Limited (ZURA)? Wall Street Analysts Think 248.84%
ZURA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zura Bio Limited (ZURA) Upgraded to Buy: Here's What You Should Know
Other News for ZURA
Zura Bio Limited: Q3 2024 Financial Insights and Strategic Progress
Zura Bio GAAP EPS of -$0.26 misses by $0.13
Piper Sandler Keeps Their Buy Rating on Zura Bio (ZURA)
Zura Bio’s Strategic Positioning and Promising Asset Portfolio: A Buy Recommendation by Analyst Faisal Khurshid
Zura Bio initiated with an Outperform at Leerink